ROBERT J DELUCCIA

CIK 1127423 · Executive Chairman · last filed 2026-04-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.59M

Companies

3

Total Filings

16

Lifetime Open-Market Net

$174.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACXP Director 1,014,043 $1.57 $1.59M $149.7K 9 2026-04-22
PLx Pharma Inc. (PLXP) Delisted Executive Chairman $0.09 $0 1 2017-04-20
PLx Pharma Inc. (DPRX) Delisted Executive Chairman 1,831,309 $25.0K 3 2016-01-21

Recent Filings · Page 2 of 2

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-01-21 PLx Pharma Inc. (DPRX) Delisted Grant (A) $0 EDGAR
2015-01-29 PLx Pharma Inc. (DPRX) Delisted Grant (A) $0 EDGAR
2014-03-19 PLx Pharma Inc. (DPRX) Delisted Mixed +2,083 $25.0K EDGAR
2008-01-04 Buy (P) +5,000 $2.9K
2007-10-12 Mixed +41,667 $25.0K
2007-02-26 Grant (A) $0
Showing 1116 of 16
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.